11.12.13
SourceOne Global Partners, Chicago, IL, has reached an agreement with Santal Solutions, Appleton, WI, wherein SourceOne was awarded exclusive global distribution rights for Santal's signature blood sugar health compound, GymnePure, its patented Gymnema sylvestre extract.
Commented on extract,Arun K. Chatterji, PhD, founder, chairman and CEO of Santal Solutions explained, “GymnePure has been shown to increase insulin production at a much lower dosage level than standard Gymnema sylvestre extracts. Further, multiple studies have shown the extract's significant effect on promoting healthy blood glucose levels.”
Jesse Lopez, Founder and CEO of SourceOne, stated, “This agreement with Santal Solutions and GymnePure ensures we continue to add to our robust IP portfolio with health condition-specific products for the most pressing consumer health concerns.”
Commented on extract,Arun K. Chatterji, PhD, founder, chairman and CEO of Santal Solutions explained, “GymnePure has been shown to increase insulin production at a much lower dosage level than standard Gymnema sylvestre extracts. Further, multiple studies have shown the extract's significant effect on promoting healthy blood glucose levels.”
Jesse Lopez, Founder and CEO of SourceOne, stated, “This agreement with Santal Solutions and GymnePure ensures we continue to add to our robust IP portfolio with health condition-specific products for the most pressing consumer health concerns.”
